25 Aug 2017

Kate: I’m making a difference

Kate’s mother died of acute myloid leukaemia at the age of 34, leaving behind four young children. When Kate reached the same age, she took up running and began to raise money for our cause

My mum died after a short battle with acute myeloid leukaemia. She was 34 and left four children behind – I was eight years old.

 I started running nearly three years ago, the year I turned 34. I started with 10k a month for a year, building up to half marathons last year.

I’ve always watched the London Marathon in awe, thinking I would love to do it but never thought it possible. I chose to run it for Leukaemia UK because I wanted to find a leukaemia charity that was relatively local, so that by raising money I would make a difference.

Kate completed the Great North Run and the Great South Run for Leukaemia UK in 2016, then the London Marathon and the Royal Parks Half Marathon in 2017. She raised more than £3,000 for Leukaemia UK – what an inspiration!

We are delighted that Kate has chosen to support us in memory of her mother and are so impressed with her dedication and determination. Thank you!

Read further inspiring fundraising stories, including Esther’s half marathon journey.

Read more stories from our community.

 

 

 

 

Related posts

Championing groundbreaking therapies and emotional support

25 June 2019

Championing groundbreaking therapies and emotional support

We are proud to be at the forefront of funding innovative research into gene therapy treatments

The first ever leukaemia-dedicated pathway to improve diagnosis, treatment and care

8 July 2025

The first ever leukaemia-dedicated pathway to improve diagnosis, treatment and care

The Best Practice Timed Pathway We’re delighted to share that Leukaemia UK, in partnership with Lymphoma Action and Myeloma UK, is working with the NHS England Cancer programme team to…

Leukaemia UK research paves the way for personalised lymphoma treatment

19 June 2023

Leukaemia UK research paves the way for personalised lymphoma treatment

Despite promising trials, standard treatment for diffuse large B-cell lymphoma (DLBCL) hasn’t changed in a decade. New treatment strategies for this type of blood cancer are urgently needed. Could the…

Leukaemia UK drives forward progress for leukaemia research through five new John Goldman Fellowships for 2021

18 October 2021

Leukaemia UK drives forward progress for leukaemia research through five new John Goldman Fellowships for 2021

Leukaemia UK announces five new John Goldman Fellows for 2021 to accelerate progress and stop the disease devastating lives.